ALDOSTERONE SECRETION AND PRIMARY AND MALIGNANT HYPERTENSION *
Open Access
- 1 July 1960
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 39 (7) , 1091-1106
- https://doi.org/10.1172/jci104124
Abstract
Utilizing a technique of isotope dilution, the amount of aldosterone actually secreted by the adrenal glands per 24 hours has been measured in patients with hypertension. Patients with benign essential hypertension have normal secretion rates of from 180 to 330 [mu]gms/day. In contrast, patients with malignant hypertension usually exhibit marked hypersecretion of aldosterone. In addition to the differences in the clinical picture between patients with malignant hypertension and those with Conn''s syndrome, the hypersecretion of aldosterone may differ in its origin. In malignant hypertension it seems to be due to bilateral adrenal hyperfunction rather than to an adrenal adenoma. Hypersecretion of aldosterone in the syndrome of malignant hypertension may prove to be a secondary or concomitant phenomenon. However, the results presented here make it reasonable to consider the possibility that hypersecretion of aldosterone plays a casual role in malignant hypertension.Keywords
This publication has 23 references indexed in Scilit:
- Primary aldosteronism.1958
- Further Studies on Urinary Aldosterone in Human Arterial Hypertension.Experimental Biology and Medicine, 1958
- The isolation of a urinary metabolite of aldosterone and its use to measure the rate of secretion of aldosterone by the adrenal cortex of man.1958
- Potassium deficiency of renal and adrenal originThe American Journal of Medicine, 1957
- MALIGNANT HYPERTENSION WITH INCREASED SECRETION OF ALDOSTERONE AND DEPLETION OF POTASSIUMThe Lancet, 1956
- THE EFFECT OF POTASSIUM CHLORIDE ON HYPONATREMIA 1Journal of Clinical Investigation, 1954
- Potassium Depletion and AlkalosisNew England Journal of Medicine, 1954
- Isolierung eines neuen kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den MineralstoffwechselCellular and Molecular Life Sciences, 1953
- SUSTAINED HYPERTENSION FOLLOWING THE ADMINISTRATION OF DESOXYCORTICOSTERONE ACETATEThe Journal of Experimental Medicine, 1951
- Malignant Hypertension Produced by Treatment with Desoxycorticosterone Acetate and Sodium Chloride.1943